Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix
Endotronix Receives FDA Premarket Approval of the Cordella™ PA Sensor System for the Treatment of Heart Failure
Merck signs $3bn deal for Kate Bingham-backed eye disease biotechRead More
SV Health Investors-created EyeBio to be acquired by MSD for up to $3 billion
Nanopath Receives $4 Million in Grants from National Institutes of Health and National Science Foundation
QurAlis to Present Data That Show its Splice-Switching ASOs Restore UNC13A Function in ALS and Frontotemporal Dementia
SV investment has resulted in the approval of 24 novel therapeutics
SV Health Investors bolsters senior biotech team - appoints Nikola Trbovic as Managing Partner and hires Jamil Beg as Partner
Hightop Health adds industry veteran to Board of Directors - Seasoned CEO and McLean Hospital Board Chair joins Hightop’s executive leadership
Merck to Acquire Caraway Therapeutics, Inc.
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
SV Health Investors partners with HIT Executives Dave Dyell and Marc Hirshfield to Lead Recapitalization of Innovative Consulting Group
- 1 August 2018Portfolio NewsEvidation Health Announces $30M in New Funding
- 26 July 2018Portfolio NewsSutro Biopharma Announced $85.4 Million Series E Round
- 25 July 2018Portfolio NewsDDF notes Alector raises $133 million in Series E Financing
- 19 July 2018SV NewsBill Gates announces new investment in Alzheimer’s research to help launch Diagnostics Accelerator
- 17 July 2018SV NewsKate Bingham’s 'The Moment' interview with Maxinne Mawhinney
- 25 June 2018SV NewsDementia Discovery Fund Announces the Appointment of Angus Grant PhD as CEO
- 25 June 2018SV NewsThe Dementia Discovery Fund Raises $350 Million
- 19 June 2018SV NewsDDF Announce Research Collaboration with Immuneering
- 24 May 2018Portfolio NewsSchweiger Dermatology Group Announces $100 Million Investment from LNK Partners
- 4 May 2018Portfolio NewsScience 2 Startup Symposium Convened Over 230 Academic Researchers, Venture Capitalists, Entrepreneurs, and Pharmaceutical Executives, Creating Connections That Can Advance Scientific Innovation and Entrepreneurship
- 18 April 2018Portfolio NewsWSJ Health Forum - 22 May 2018
- 12 April 2018SV NewsSV Health Investors to Co-Host Symposium Featuring Therapeutics Startup Ideas from World's Top Academic Research Institutions